Hybrid materials based on montmorillonite and citostatic drugs: Preparation and characterization

Applied Clay Science

Volumn 52, Issue 1-2, 2011, Pages 62-68

  Iliescu, Ruxandra Irina ^a   Andronescu, Ecaterina ^a   Voicu, Georgeta ^a   Ficai, Anton ^a   Covaliu, Cristina Ileana ^a  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

Adsorption; Citostatics; Intercalation; Montmorillonite

Indexed keywords

ACTIVE SUBSTANCE; BEFORE AND AFTER; CARBOPLATIN; CITOSTATICS; DRUG DELIVERY SYSTEM; DRUG SOLUTIONS; EXPERIMENTAL TECHNIQUES; INTERLAYER SPACINGS; IRINOTECAN; MINERAL PHASE; MONTMORILLONITE; SEM; SODIUM MONTMORILLONITE; STABLE SUSPENSIONS; THERMAL ANALYSIS; WASHING STEPS; WATER MOLECULE;

ADSORPTION; CHEMOTHERAPY; CHLORINE COMPOUNDS; CLAY MINERALS; DRUG DELIVERY; DRUG PRODUCTS; INFRARED SPECTROSCOPY; MINERALS; SCANNING ELECTRON MICROSCOPY; SILICATE MINERALS; SODIUM; THERMOANALYSIS; WASHING; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

HYBRID MATERIALS;

ADSORPTION; FTIR SPECTROSCOPY; HYBRID; HYDROPHOBICITY; MONTMORILLONITE; SCANNING ELECTRON MICROSCOPY; SODIUM; X-RAY DIFFRACTION;

EID: 79953035871     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2011.01.031     Document Type: Article

References (24)

1. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007, 36:22-36.
2. Carstensen J.T., Kenneth S. Nature of bonding in montmorillonite adsorbates I: surface adsorption. J. Pharm. Sci. 1971, 60:733-735.
3. Castela-Papin N., Cai S., Vatier J., Keller F., Souleau C.H., Farinotti R. Drug interactions with diosmectite: a study using the artificial stomach-duodenum model. Int. J. Pharm. 1999, 182:111-119.
4. Chen B.Y., Lee Y.H., Lin W.C., Lin F.H., Lin K.F. Understanding the characteristics of l-ascorbic acid-montmorillonite nanocomposite: chemical structure and biotoxicity. Biomed. Eng. Appl. Basis Comm. 2006, 18:30-36.
5. Choy J.H., Choi S.J., Oh J.M., Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci. 2007, 36:122-132.
6. Dobrozski, D. J., 2000. Oral liquid mucoadhesive compositions. US Patent Appl. No.: 10/021,327.
7. Forni F., Iannuccelli V., Coppi G., Bernabei M.T. Effect of montmorillonite on drug release from polymeric matrices. Arch. Pharm. 1989, 322:789-793.
8. Joshi G.V., Patel H.A., Kevadiya B.D., Bajaj H.C. Montmorillonite intercalated with vitamin B1 as drug carrier. Appl. Clay Sci. 2009, 45:248-253.
9. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm. 2009, 374:53-57.
10. Kawase M., Hayashi Y., Kinoshita F., Yamato E., Miyazaki J., Yamakawa J., Ishida T., Tamura M., Yagi K. Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine. Biol. Pharm. Bull. 2004, 27(12):2049-2051.
11. Kenneth S., Carstensen J.T. Nature of bonding in montmorillonite adsorbates II: bonding as an ion-dipole interaction. J. Pharm. Sci. 1972, 61:420-424.
12. Krikorian V., Nowak A.P., Deming J. Clay minerals and anionic clays. Molecules 2008, 13:2361.
13. Lee W.F., Fu Y.T. Effect of montmorillonite on the swelling behaviour and drug-release behaviour of nanocomposite hydrogels. J. Appl. Polym. Sci. 2003, 89:3652-3660.
14. Lee W.F., Chen Y.C. Effect of bentonite on the physical properties and drug release behaviour of poly(AA-co-PEGMEA)/bentonite nanocomposite hydrogels for mucoadhesive. Appl. Polym. Sci. 2004, 91:29342941.
15. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23(9):1981-1987.
16. Marenzi, G., Bolognese, A., Califano, L., Calignano, A., Constantino, U., Sammartino, G., Vittoria, V., 2008. Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof. USPTO Patent Appl. 20080299202.
17. McGinity J.W., Lach J.L. In vitro adsorption of various pharmaceuticals to montmorillonite. J. Pharm. Sci. 1976, 65(6):896-902.
18. Patel H.A., Somani R.S., Bajaj H.C. Nanoclays for polymer nanocomposites, paints, inks, greases and cosmetics formulation, drug delivery vehicle and waste water treatment. Bull. Mater. Sci. 2006, 29:133-145.
19. Si-Shen F., Lin M., Panneerselvan A., Chee Wee G., Wenyou Z. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 2009, 30:3297-3306.
20. Vikas, Raghupathi K., Sanjay G. Ion-exchange resins: carrying drug delivery forward. DDT 2001, 6(17):905-914.
21. Viseras C., Cerezo P., Sanchez R., Salcedo I., Aguzzi C. Current challenges in clay minerals for drug delivery. Appl. Clay Sci 2010, 48:291-295.
22. Zheng J., Wang H., Zhuang H., Lifei X.I. Intercalation of amido-cationic drug with montmorillonite. Mat. Sci. Eng. 2006, 22:2.
23. Wai K.N., Banker G.S. Some physicochemical properties of the montmorillonites. J. Pharm. Sci 1996, 55(11):1215-1220.
24. Wang S.F., Shen L., Tong Y.J., Chen L., Phang I.Y., Lim P.Q., Liu T.X. Biopolymer chitosan/montmorillonite nanocomposites: preparation and characterization. Polymer Degradation and Stability 2005, 90:123-131.